In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (the SEBI Listing Regulations), Privi Speciality Chemicals has informed that the Board of Directors of the Company at their meeting held on Friday, December 19, 2025, which commenced at 03:00 pm and concluded at 05:00 pm have considered and approved: The Scheme of Amalgamation of Privi Fine Sciences Private Limited, (PFSPL or Transferor Company 1) and Privi Biotechnologies Private Limited, a wholly owned subsidiary of the Company (PBPL or Transferor Company 2) (PFSPL together with PBPL, Transferor Companies), with Privi Speciality Chemicals Limited (PSCL or Transferee Company) and their respective shareholders (hereinafter referred to as scheme of Amalgamation) under Sections 230 to232of the Companies Act, 2013 and other applicable laws. The Scheme is subject to the approval of the shareholders, creditors, the Hon’ble National Company Law Tribunal (NCLT) and such other regulatory authorities, as maybe required, under the applicable law. The disclosure in respect to the aforesaid Scheme as required under Regulation 30 read with Schedule III, part A to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations) read with the SEBI Circular No SEBI/HO11FD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 is attached as Annexure A.
The above information is a part of company’s filings submitted to BSE.
